Sami Nazzal
Overview
Explore the profile of Sami Nazzal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain A, Shrewsbury R, Mattingly A, Draugalis J, Nutan M, Nazzal S, et al.
Am J Pharm Educ
. 2023 Oct;
87(10):100117.
PMID: 37852686
Objective: To determine the extent of compounding education (CE) offered in United States (US) doctor of pharmacy curricula. Methods: A 24-item survey instrument addressing various aspects of CE was developed...
2.
Elsanhoury R, Alasmari A, Parupathi P, Jumaa M, Al-Fayoumi S, Kumar A, et al.
Int J Pharm
. 2023 Sep;
645:123384.
PMID: 37678472
The current work aims to design and provide a preliminary IND-enabling study of selective BMX inhibitors for cancer therapeutics development. BMX is an emerging target, more notably in oncological and...
3.
Kamal M, Akter S, Al Hagbani T, Salawi A, Nazzal S
Pharm Dev Technol
. 2021 Oct;
26(10):1102-1109.
PMID: 34645368
The objective of the present study was to investigate the feasibility of formulating and loading Curcumin SEDDS (Self-Emulsified Drug Delivery Systems) into films made from Soluplus as the film-forming polymer....
4.
Salawi A, Sonju J, Kamal M, Abu-Fayyad A, Al Hagbani T, Nazzal S
Drug Dev Ind Pharm
. 2021 Oct;
47(8):1335-1341.
PMID: 34622736
Objective: The goals of this study were to (1) delineate a technique to prepare stable aqueous vitamin E/Soluplus dispersions; (2) characterize films cast from the aqueous dispersions; and (3) demonstrate...
5.
Rawas-Qalaji M, Bafail R, Ahmed I, Uddin M, Nazzal S
Int J Pharm
. 2021 Jul;
606:120898.
PMID: 34310952
Atropine sulfate (AS) auto-injectors are the only approved antidote for out-of-hospital emergency treatment of organophosphates (OP) toxicity. However, they are only available for military use and require the administration of...
6.
Abu-Fayyad A, Nazzal S
J Am Oil Chem Soc
. 2021 Feb;
94(9):1209-1217.
PMID: 33518766
Vitamin E refers to a family of eight tocopherols (T) and tocotrienol (T3) isomers. Due to the unique pharmacological and anticancer activity of the individual isomers, there is a need...
7.
Kamal M, Akter S, Lin C, Nazzal S
Arch Pharm Res
. 2020 Mar;
43(4):371-384.
PMID: 32152852
Sulforaphane is an isothiocyanate compound that has been derived from cruciferous vegetables. It was shown in numerous studies to be active against multiple cancer types including pancreatic, prostate, breast, lung,...
8.
Al Hagbani T, Kamal M, Nazzal S
Drug Dev Ind Pharm
. 2020 Feb;
46(4):539-546.
PMID: 32090628
Developing chewing gum tablets (CGTs) with high drug loads is a challenge due to the loss of mastication properties. We postulated that poor mastication properties of such gums could be...
9.
Shakhwar S, Darwish R, Kamal M, Nazzal S, Pallerla S, Fayyad A
Pharm Dev Technol
. 2019 Dec;
25(4):510-516.
PMID: 31858867
Tocosol™ is a tocopherol-based paclitaxel (PTX) nanoemulsion consisting of α-tocopherol (α-T) isomer of vitamin E as a solubilizer and vitamin E TPGS as the primary emulsifier. Despite its positive attributes...
10.
Khiste S, Liu Z, Roy K, Uddin M, Hosain S, Gu X, et al.
Mol Cancer Ther
. 2019 Oct;
19(2):564-574.
PMID: 31645443
Ceramide (Cer) is an active cellular sphingolipid that can induce apoptosis or proliferation-arrest of cancer cells. Nanoparticle-based delivery offers an effective approach for overcoming bioavailability and biopharmaceutics issues attributable to...